FDA approves Biogen’s Alzheimer’s drug

Posted on AllSides June 7th, 2021
From The Right

The Food and Drug Administration (FDA) on Monday approved Biogen’s Alzheimer’s drug, marking the first new authorized therapy to treat the disease in nearly two decades. The drug, Aduhelm (aducanumab), had received mixed reviews following earlier clinical trials.

In a statement following the approval, Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, said the agency used the Accelerated Approval pathway, which is when the FDA "approves a drug for a serious or life-threatening illness that may provide meaningful therapeutic benefit over existing treatments when the drug is...

Read full story
https://www.foxbusiness.com/lifestyle/fda-approves-biogens-alzheimers-drug

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right